An International Publisher for Academic and Scientific Journals
Author Login 
Scholars Journal of Applied Medical Sciences | Volume-10 | Issue-12
Epidemio-Clinical and Therapeutic Aspects of Uterine Fibroma at Fousseyni Daou Hospital in Kayes
Dembele, S, Diassana, M, Macalou, B, Sidibe, A, Hamidou, A, Doumbia, F, Haidara, M, Kane, F, Sylla, C, Bocoum, A, Traore, S
Published: Dec. 30, 2022 | 102 76
DOI: 10.36347/sjams.2022.v10i12.068
Pages: 2486-2490
Downloads
Abstract
Introduction: Leiomyoma, commonly called fibroma, is a benign tumor most common in women of childbearing age. The aim was to study the epidemio-clinical and therapeutic aspects of uterine fibroma at the FOUSSEYNI DAOU in KAYES hospital. Materials and methods: This was a cross-sectional descriptive study with prospective data collection in the obstetric gynecology departement of the FOUSSEYNI DAOU in KAYES hospital from January 01, 2019 to June 30, 2020. The study involved all the patients in whom the clinical and paraclinical diagnosis of uterine fibroma had been made and whose management had been carried out in the departement. All patients admitted to the departement for other reasons were excluded from this study. Results: During the study period we collected 40 cases of uterinefibroma out of a total of 4644 gynecology consultations of 0.86%. The most represented age group was 20-34 years old. Pelvic pain, desire for pregnancy (sterility) and genital hemorrhage were the most common reasons for consultation with the respective frequencies of 35%, 35% and 17.5%. The diagnosis of uterine fibroma was confirmed on ultrasound in 100% of patients. No treatement was observed in 25% of patients, medical treatment was performed in 17.5% of patients, myomectomy was performed in 45% of patients and hysterectomy in 12.5% of patients. The postoperative course was complicated in 47.83 % of patients. No case of death was observed. No case of death was observed. Conclusion: Uterine fibroid is a relatively common pathology in our department, its frequency has been estimated at 0.86%. It mainly affects the 20-34 age group.